Read our blog posts below.
With $7 million in funding, Altro Health is building infrastructure for wellness businesses ready to offer more under their own brands.
Google and Meta won’t approve telehealth ads for weight management, hormone health and wellness programs without LegitScript certification. Here’s what it costs, who needs it, and how long it takes.
Glutathione has clinical data behind it, including one of the strongest evidence bases of any wellness compound. This is what the research shows.
TRT is everywhere. Here’s what the data says about who benefits, what the risks are, and why it’s rarely just about testosterone alone.
Health coaches are hitting a scope-of-practice wall clients keep pushing against. Here’s the medically-supervised growth model solving it.
Topical GHK-Cu skincare is more than a passing trend. It’s a copper peptide backed by 50 years of research. Here’s what the clinical data shows.
GLP-1s have moved far beyond weight loss. Here’s what the latest research shows about their effects on heart, kidneys, liver, sleep, brain, and cravings.
Competing on price attracts the wrong clients. See how wellness business owners use premium positioning and clinical value to grow revenue and retention.
Women have more testosterone than estrogen, but testosterone for women is barely tested or treated. Here’s why that’s about to change.
Sourcing GLP-1s in 2026 looks very different than it did two years ago. Here’s how to navigate the new legal landscape, and what to ask a potential pharmacy partner.
Lyv Health is now Altro Health, the same team and mission with a name that reflects where we're going: giving wellness businesses the clinical infrastructure to offer labs, prescriptions, and more under their own brand, and grow.